Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction-Reference-Cited by-同舟云学术

Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction

Published:2009-12 Issue:8 Volume:20 Page:635-641
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Van Dreden Patrick,Rousseau Aurélie,Savoure Arnaud,Lenormand Bernard,Fontaine Sylvianne,Vasse Marc

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference52 articles.

1. Atherosclerosis.;Nature,2000

2. Inflammation and atherosclerosis;Libby;Circulation,2002

3. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface;Esmon;FASEB J,1995

4. Thrombomodulin is present in human plasma and urine;Ishii;J Clin Invest,1985

5. Plasma thrombomodulin: new approach of endothelium damage;Seigneur;Int Angiol,1993

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures;TH Open;2022-03-17

2. Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study;Hemato;2022-02-22

3. Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells;Thrombosis Research;2020-03

4. Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study;Clinical and Applied Thrombosis/Hemostasis;2020-01-01

5. Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study;Blood Cancer Journal;2018-11